Download pdf
Biotechnology and crisis management developments during the COVID-19 pandemic: Comprehensive analysis
- 1 University of Connecticut
* Author to whom correspondence should be addressed.
Abstract
Over the period from 2020 to 2023, a four-year non-military battle drew to a close, marking the end of the COVID-19 pandemic that will be etched into history. During this time frame, policies and technologies aimed at combating the virus were developed, ultimately saving numerous lives and enhancing people's efficacy in battling the virus while demonstrating unwavering determination. However, some less mature biological nucleic acid technologies and some controversial policy bases are still being improved. Through the development of biotechnology levels and policies, the research and development of three mRNA vaccines, health codes and RT-PCR nucleic acid detection methods have greatly improved the efficiency of epidemic prevention and control. The government's policy of controlling speech and behavior at the initial stage of the outbreak brought people together to fight against the virus. These technologies are being researched to reduce the number of casualties and minimize losses. For example, circRNA or saRNA vaccines are still in the research stage. If these more advanced techniques are put into use, it will undoubtedly greatly increase the means of fighting against the virus. This is also the direction and key for future research and development.
Keywords
mRNA Vaccines, crisis management, healthcare QR Code, RT-PCR techniques
[1]. Worobey M 2021 Dissecting the early COVID-19 cases in Wuhan Science 374 6572 1202-1204
[2]. Majumder J & Minko T 2021 Recent developments on therapeutic and diagnostic approaches for COVID-19 The AAPS journal 23 1-22
[3]. Fang E Liu X Li M et al 2022 Advances in COVID-19 mRNA vaccine development Signal transduction and targeted therapy 7 1 94
[4]. Majumder J & Minko T 2021 Recent developments on therapeutic and diagnostic approaches for COVID-19 The AAPS journal 23 1-22
[5]. Szabó G T Mahiny A J & Vlatkovic I 2022 COVID-19 mRNA vaccines: Platforms and current developments Molecular Therapy 30 5 1850-1868
[6]. Shangguan Z Wang M Y & Sun W 2020 What caused the outbreak of COVID-19 in China: From the perspective of crisis management International journal of environmental research and public health 17 9 3279
[7]. Chen S Liu T Li X et al 2021 Health QR code application in the novel containment strategy and healthcare plan for pregnant women and children under quarantine during the summer outbreak of SARS-CoV-2 delta variant in Chengdu China: an observational study Risk Management and Healthcare Policy 4499-4510
[8]. Chen S Liu T Li X et al 2021 Health QR code application in the novel containment strategy and healthcare plan for pregnant women and children under quarantine during the summer outbreak of SARS-CoV-2 delta variant in Chengdu China: an observational study Risk Management and Healthcare Policy 4499-4510
[9]. Gupta N Augustine S Narayan T O’Riordan A Das A Kumar D & Malhotra B D 2021 Point-of-care PCR assays for COVID-19 detection Biosensors 11 5 141
[10]. Santhanam M Algov I & Alfonta L 2020 DNA/RNA electrochemical biosensing devices a future replacement of PCR methods for a fast epidemic containment Sensors 20 16 4648
Cite this article
Ye,Y. (2024).Biotechnology and crisis management developments during the COVID-19 pandemic: Comprehensive analysis.Theoretical and Natural Science,48,1-8.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content
About volume
Volume title: Proceedings of the Climate Change and Emerging Health Threats: Navigating the Future of Public Health - ICEGEE 2024
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).